Global Molecular Point-of-Care Testing Supply, Demand and Key Producers, 2023-2029
The global Molecular Point-of-Care Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Molecular point-of-care (POC) testing is a type of diagnostic testing that uses nucleic acid amplification techniques such as polymerase chain reaction (PCR) to rapidly detect the presence of specific genetic material, such as DNA or RNA, directly in patient samples.
This report studies the global Molecular Point-of-Care Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Molecular Point-of-Care Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Molecular Point-of-Care Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Molecular Point-of-Care Testing total market, 2018-2029, (USD Million)
Global Molecular Point-of-Care Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Molecular Point-of-Care Testing total market, key domestic companies and share, (USD Million)
Global Molecular Point-of-Care Testing revenue by player and market share 2018-2023, (USD Million)
Global Molecular Point-of-Care Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global Molecular Point-of-Care Testing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Molecular Point-of-Care Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche Molecular Diagnostics, Salignostics, Saw Diagnostics, Siemens Healthineer, Sona Nanotech, T2 Biosystems, Talis Biomedical, Thermo Fisher Scientific Inc. and Veramarx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Molecular Point-of-Care Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Molecular Point-of-Care Testing Market, By Region:
1. How big is the global Molecular Point-of-Care Testing market?
2. What is the demand of the global Molecular Point-of-Care Testing market?
3. What is the year over year growth of the global Molecular Point-of-Care Testing market?
4. What is the total value of the global Molecular Point-of-Care Testing market?
5. Who are the major players in the global Molecular Point-of-Care Testing market?
6. What are the growth factors driving the market demand?
Molecular point-of-care (POC) testing is a type of diagnostic testing that uses nucleic acid amplification techniques such as polymerase chain reaction (PCR) to rapidly detect the presence of specific genetic material, such as DNA or RNA, directly in patient samples.
This report studies the global Molecular Point-of-Care Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Molecular Point-of-Care Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Molecular Point-of-Care Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Molecular Point-of-Care Testing total market, 2018-2029, (USD Million)
Global Molecular Point-of-Care Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Molecular Point-of-Care Testing total market, key domestic companies and share, (USD Million)
Global Molecular Point-of-Care Testing revenue by player and market share 2018-2023, (USD Million)
Global Molecular Point-of-Care Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global Molecular Point-of-Care Testing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Molecular Point-of-Care Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche Molecular Diagnostics, Salignostics, Saw Diagnostics, Siemens Healthineer, Sona Nanotech, T2 Biosystems, Talis Biomedical, Thermo Fisher Scientific Inc. and Veramarx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Molecular Point-of-Care Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Molecular Point-of-Care Testing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Polymerase Chain Reaction (PCR)
- Loop-mediated Isothermal Amplification (LAMP)
- Nucleic Acid Sequence-based Amplification (NASBA)
- Infectious Diseases
- Genetic Disorders
- Pregnancy Testing
- Diagnosis of Cancer
- Pharmacogenomics
- Roche Molecular Diagnostics
- Salignostics
- Saw Diagnostics
- Siemens Healthineer
- Sona Nanotech
- T2 Biosystems
- Talis Biomedical
- Thermo Fisher Scientific Inc.
- Veramarx
- XCR Diagnostics
- Zhejiang Orient Gene Biotech
1. How big is the global Molecular Point-of-Care Testing market?
2. What is the demand of the global Molecular Point-of-Care Testing market?
3. What is the year over year growth of the global Molecular Point-of-Care Testing market?
4. What is the total value of the global Molecular Point-of-Care Testing market?
5. Who are the major players in the global Molecular Point-of-Care Testing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Molecular Point-of-Care Testing Introduction
1.2 World Molecular Point-of-Care Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Molecular Point-of-Care Testing Total Market by Region (by Headquarter Location)
1.3.1 World Molecular Point-of-Care Testing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Molecular Point-of-Care Testing Market Size (2018-2029)
1.3.3 China Molecular Point-of-Care Testing Market Size (2018-2029)
1.3.4 Europe Molecular Point-of-Care Testing Market Size (2018-2029)
1.3.5 Japan Molecular Point-of-Care Testing Market Size (2018-2029)
1.3.6 South Korea Molecular Point-of-Care Testing Market Size (2018-2029)
1.3.7 ASEAN Molecular Point-of-Care Testing Market Size (2018-2029)
1.3.8 India Molecular Point-of-Care Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Molecular Point-of-Care Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Molecular Point-of-Care Testing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Molecular Point-of-Care Testing Consumption Value (2018-2029)
2.2 World Molecular Point-of-Care Testing Consumption Value by Region
2.2.1 World Molecular Point-of-Care Testing Consumption Value by Region (2018-2023)
2.2.2 World Molecular Point-of-Care Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Molecular Point-of-Care Testing Consumption Value (2018-2029)
2.4 China Molecular Point-of-Care Testing Consumption Value (2018-2029)
2.5 Europe Molecular Point-of-Care Testing Consumption Value (2018-2029)
2.6 Japan Molecular Point-of-Care Testing Consumption Value (2018-2029)
2.7 South Korea Molecular Point-of-Care Testing Consumption Value (2018-2029)
2.8 ASEAN Molecular Point-of-Care Testing Consumption Value (2018-2029)
2.9 India Molecular Point-of-Care Testing Consumption Value (2018-2029)
3 WORLD MOLECULAR POINT-OF-CARE TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Molecular Point-of-Care Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Molecular Point-of-Care Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Molecular Point-of-Care Testing in 2022
3.2.3 Global Concentration Ratios (CR8) for Molecular Point-of-Care Testing in 2022
3.3 Molecular Point-of-Care Testing Company Evaluation Quadrant
3.4 Molecular Point-of-Care Testing Market: Overall Company Footprint Analysis
3.4.1 Molecular Point-of-Care Testing Market: Region Footprint
3.4.2 Molecular Point-of-Care Testing Market: Company Product Type Footprint
3.4.3 Molecular Point-of-Care Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Molecular Point-of-Care Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Molecular Point-of-Care Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Molecular Point-of-Care Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Molecular Point-of-Care Testing Consumption Value Comparison
4.2.1 United States VS China: Molecular Point-of-Care Testing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Molecular Point-of-Care Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Molecular Point-of-Care Testing Companies and Market Share, 2018-2023
4.3.1 United States Based Molecular Point-of-Care Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Molecular Point-of-Care Testing Revenue, (2018-2023)
4.4 China Based Companies Molecular Point-of-Care Testing Revenue and Market Share, 2018-2023
4.4.1 China Based Molecular Point-of-Care Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Molecular Point-of-Care Testing Revenue, (2018-2023)
4.5 Rest of World Based Molecular Point-of-Care Testing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Molecular Point-of-Care Testing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Molecular Point-of-Care Testing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Molecular Point-of-Care Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Polymerase Chain Reaction (PCR)
5.2.2 Loop-mediated Isothermal Amplification (LAMP)
5.2.3 Nucleic Acid Sequence-based Amplification (NASBA)
5.3 Market Segment by Type
5.3.1 World Molecular Point-of-Care Testing Market Size by Type (2018-2023)
5.3.2 World Molecular Point-of-Care Testing Market Size by Type (2024-2029)
5.3.3 World Molecular Point-of-Care Testing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Molecular Point-of-Care Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Infectious Diseases
6.2.2 Genetic Disorders
6.2.3 Pregnancy Testing
6.2.4 Diagnosis of Cancer
6.2.5 Diagnosis of Cancer
6.3 Market Segment by Application
6.3.1 World Molecular Point-of-Care Testing Market Size by Application (2018-2023)
6.3.2 World Molecular Point-of-Care Testing Market Size by Application (2024-2029)
6.3.3 World Molecular Point-of-Care Testing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche Molecular Diagnostics
7.1.1 Roche Molecular Diagnostics Details
7.1.2 Roche Molecular Diagnostics Major Business
7.1.3 Roche Molecular Diagnostics Molecular Point-of-Care Testing Product and Services
7.1.4 Roche Molecular Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Molecular Diagnostics Recent Developments/Updates
7.1.6 Roche Molecular Diagnostics Competitive Strengths & Weaknesses
7.2 Salignostics
7.2.1 Salignostics Details
7.2.2 Salignostics Major Business
7.2.3 Salignostics Molecular Point-of-Care Testing Product and Services
7.2.4 Salignostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Salignostics Recent Developments/Updates
7.2.6 Salignostics Competitive Strengths & Weaknesses
7.3 Saw Diagnostics
7.3.1 Saw Diagnostics Details
7.3.2 Saw Diagnostics Major Business
7.3.3 Saw Diagnostics Molecular Point-of-Care Testing Product and Services
7.3.4 Saw Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Saw Diagnostics Recent Developments/Updates
7.3.6 Saw Diagnostics Competitive Strengths & Weaknesses
7.4 Siemens Healthineer
7.4.1 Siemens Healthineer Details
7.4.2 Siemens Healthineer Major Business
7.4.3 Siemens Healthineer Molecular Point-of-Care Testing Product and Services
7.4.4 Siemens Healthineer Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Siemens Healthineer Recent Developments/Updates
7.4.6 Siemens Healthineer Competitive Strengths & Weaknesses
7.5 Sona Nanotech
7.5.1 Sona Nanotech Details
7.5.2 Sona Nanotech Major Business
7.5.3 Sona Nanotech Molecular Point-of-Care Testing Product and Services
7.5.4 Sona Nanotech Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Sona Nanotech Recent Developments/Updates
7.5.6 Sona Nanotech Competitive Strengths & Weaknesses
7.6 T2 Biosystems
7.6.1 T2 Biosystems Details
7.6.2 T2 Biosystems Major Business
7.6.3 T2 Biosystems Molecular Point-of-Care Testing Product and Services
7.6.4 T2 Biosystems Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 T2 Biosystems Recent Developments/Updates
7.6.6 T2 Biosystems Competitive Strengths & Weaknesses
7.7 Talis Biomedical
7.7.1 Talis Biomedical Details
7.7.2 Talis Biomedical Major Business
7.7.3 Talis Biomedical Molecular Point-of-Care Testing Product and Services
7.7.4 Talis Biomedical Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Talis Biomedical Recent Developments/Updates
7.7.6 Talis Biomedical Competitive Strengths & Weaknesses
7.8 Thermo Fisher Scientific Inc.
7.8.1 Thermo Fisher Scientific Inc. Details
7.8.2 Thermo Fisher Scientific Inc. Major Business
7.8.3 Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Product and Services
7.8.4 Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
7.8.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
7.9 Veramarx
7.9.1 Veramarx Details
7.9.2 Veramarx Major Business
7.9.3 Veramarx Molecular Point-of-Care Testing Product and Services
7.9.4 Veramarx Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Veramarx Recent Developments/Updates
7.9.6 Veramarx Competitive Strengths & Weaknesses
7.10 XCR Diagnostics
7.10.1 XCR Diagnostics Details
7.10.2 XCR Diagnostics Major Business
7.10.3 XCR Diagnostics Molecular Point-of-Care Testing Product and Services
7.10.4 XCR Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 XCR Diagnostics Recent Developments/Updates
7.10.6 XCR Diagnostics Competitive Strengths & Weaknesses
7.11 Zhejiang Orient Gene Biotech
7.11.1 Zhejiang Orient Gene Biotech Details
7.11.2 Zhejiang Orient Gene Biotech Major Business
7.11.3 Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Product and Services
7.11.4 Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Zhejiang Orient Gene Biotech Recent Developments/Updates
7.11.6 Zhejiang Orient Gene Biotech Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Molecular Point-of-Care Testing Industry Chain
8.2 Molecular Point-of-Care Testing Upstream Analysis
8.3 Molecular Point-of-Care Testing Midstream Analysis
8.4 Molecular Point-of-Care Testing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Molecular Point-of-Care Testing Introduction
1.2 World Molecular Point-of-Care Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Molecular Point-of-Care Testing Total Market by Region (by Headquarter Location)
1.3.1 World Molecular Point-of-Care Testing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Molecular Point-of-Care Testing Market Size (2018-2029)
1.3.3 China Molecular Point-of-Care Testing Market Size (2018-2029)
1.3.4 Europe Molecular Point-of-Care Testing Market Size (2018-2029)
1.3.5 Japan Molecular Point-of-Care Testing Market Size (2018-2029)
1.3.6 South Korea Molecular Point-of-Care Testing Market Size (2018-2029)
1.3.7 ASEAN Molecular Point-of-Care Testing Market Size (2018-2029)
1.3.8 India Molecular Point-of-Care Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Molecular Point-of-Care Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Molecular Point-of-Care Testing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Molecular Point-of-Care Testing Consumption Value (2018-2029)
2.2 World Molecular Point-of-Care Testing Consumption Value by Region
2.2.1 World Molecular Point-of-Care Testing Consumption Value by Region (2018-2023)
2.2.2 World Molecular Point-of-Care Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Molecular Point-of-Care Testing Consumption Value (2018-2029)
2.4 China Molecular Point-of-Care Testing Consumption Value (2018-2029)
2.5 Europe Molecular Point-of-Care Testing Consumption Value (2018-2029)
2.6 Japan Molecular Point-of-Care Testing Consumption Value (2018-2029)
2.7 South Korea Molecular Point-of-Care Testing Consumption Value (2018-2029)
2.8 ASEAN Molecular Point-of-Care Testing Consumption Value (2018-2029)
2.9 India Molecular Point-of-Care Testing Consumption Value (2018-2029)
3 WORLD MOLECULAR POINT-OF-CARE TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Molecular Point-of-Care Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Molecular Point-of-Care Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Molecular Point-of-Care Testing in 2022
3.2.3 Global Concentration Ratios (CR8) for Molecular Point-of-Care Testing in 2022
3.3 Molecular Point-of-Care Testing Company Evaluation Quadrant
3.4 Molecular Point-of-Care Testing Market: Overall Company Footprint Analysis
3.4.1 Molecular Point-of-Care Testing Market: Region Footprint
3.4.2 Molecular Point-of-Care Testing Market: Company Product Type Footprint
3.4.3 Molecular Point-of-Care Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Molecular Point-of-Care Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Molecular Point-of-Care Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Molecular Point-of-Care Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Molecular Point-of-Care Testing Consumption Value Comparison
4.2.1 United States VS China: Molecular Point-of-Care Testing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Molecular Point-of-Care Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Molecular Point-of-Care Testing Companies and Market Share, 2018-2023
4.3.1 United States Based Molecular Point-of-Care Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Molecular Point-of-Care Testing Revenue, (2018-2023)
4.4 China Based Companies Molecular Point-of-Care Testing Revenue and Market Share, 2018-2023
4.4.1 China Based Molecular Point-of-Care Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Molecular Point-of-Care Testing Revenue, (2018-2023)
4.5 Rest of World Based Molecular Point-of-Care Testing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Molecular Point-of-Care Testing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Molecular Point-of-Care Testing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Molecular Point-of-Care Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Polymerase Chain Reaction (PCR)
5.2.2 Loop-mediated Isothermal Amplification (LAMP)
5.2.3 Nucleic Acid Sequence-based Amplification (NASBA)
5.3 Market Segment by Type
5.3.1 World Molecular Point-of-Care Testing Market Size by Type (2018-2023)
5.3.2 World Molecular Point-of-Care Testing Market Size by Type (2024-2029)
5.3.3 World Molecular Point-of-Care Testing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Molecular Point-of-Care Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Infectious Diseases
6.2.2 Genetic Disorders
6.2.3 Pregnancy Testing
6.2.4 Diagnosis of Cancer
6.2.5 Diagnosis of Cancer
6.3 Market Segment by Application
6.3.1 World Molecular Point-of-Care Testing Market Size by Application (2018-2023)
6.3.2 World Molecular Point-of-Care Testing Market Size by Application (2024-2029)
6.3.3 World Molecular Point-of-Care Testing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche Molecular Diagnostics
7.1.1 Roche Molecular Diagnostics Details
7.1.2 Roche Molecular Diagnostics Major Business
7.1.3 Roche Molecular Diagnostics Molecular Point-of-Care Testing Product and Services
7.1.4 Roche Molecular Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Molecular Diagnostics Recent Developments/Updates
7.1.6 Roche Molecular Diagnostics Competitive Strengths & Weaknesses
7.2 Salignostics
7.2.1 Salignostics Details
7.2.2 Salignostics Major Business
7.2.3 Salignostics Molecular Point-of-Care Testing Product and Services
7.2.4 Salignostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Salignostics Recent Developments/Updates
7.2.6 Salignostics Competitive Strengths & Weaknesses
7.3 Saw Diagnostics
7.3.1 Saw Diagnostics Details
7.3.2 Saw Diagnostics Major Business
7.3.3 Saw Diagnostics Molecular Point-of-Care Testing Product and Services
7.3.4 Saw Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Saw Diagnostics Recent Developments/Updates
7.3.6 Saw Diagnostics Competitive Strengths & Weaknesses
7.4 Siemens Healthineer
7.4.1 Siemens Healthineer Details
7.4.2 Siemens Healthineer Major Business
7.4.3 Siemens Healthineer Molecular Point-of-Care Testing Product and Services
7.4.4 Siemens Healthineer Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Siemens Healthineer Recent Developments/Updates
7.4.6 Siemens Healthineer Competitive Strengths & Weaknesses
7.5 Sona Nanotech
7.5.1 Sona Nanotech Details
7.5.2 Sona Nanotech Major Business
7.5.3 Sona Nanotech Molecular Point-of-Care Testing Product and Services
7.5.4 Sona Nanotech Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Sona Nanotech Recent Developments/Updates
7.5.6 Sona Nanotech Competitive Strengths & Weaknesses
7.6 T2 Biosystems
7.6.1 T2 Biosystems Details
7.6.2 T2 Biosystems Major Business
7.6.3 T2 Biosystems Molecular Point-of-Care Testing Product and Services
7.6.4 T2 Biosystems Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 T2 Biosystems Recent Developments/Updates
7.6.6 T2 Biosystems Competitive Strengths & Weaknesses
7.7 Talis Biomedical
7.7.1 Talis Biomedical Details
7.7.2 Talis Biomedical Major Business
7.7.3 Talis Biomedical Molecular Point-of-Care Testing Product and Services
7.7.4 Talis Biomedical Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Talis Biomedical Recent Developments/Updates
7.7.6 Talis Biomedical Competitive Strengths & Weaknesses
7.8 Thermo Fisher Scientific Inc.
7.8.1 Thermo Fisher Scientific Inc. Details
7.8.2 Thermo Fisher Scientific Inc. Major Business
7.8.3 Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Product and Services
7.8.4 Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
7.8.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
7.9 Veramarx
7.9.1 Veramarx Details
7.9.2 Veramarx Major Business
7.9.3 Veramarx Molecular Point-of-Care Testing Product and Services
7.9.4 Veramarx Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Veramarx Recent Developments/Updates
7.9.6 Veramarx Competitive Strengths & Weaknesses
7.10 XCR Diagnostics
7.10.1 XCR Diagnostics Details
7.10.2 XCR Diagnostics Major Business
7.10.3 XCR Diagnostics Molecular Point-of-Care Testing Product and Services
7.10.4 XCR Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 XCR Diagnostics Recent Developments/Updates
7.10.6 XCR Diagnostics Competitive Strengths & Weaknesses
7.11 Zhejiang Orient Gene Biotech
7.11.1 Zhejiang Orient Gene Biotech Details
7.11.2 Zhejiang Orient Gene Biotech Major Business
7.11.3 Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Product and Services
7.11.4 Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Zhejiang Orient Gene Biotech Recent Developments/Updates
7.11.6 Zhejiang Orient Gene Biotech Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Molecular Point-of-Care Testing Industry Chain
8.2 Molecular Point-of-Care Testing Upstream Analysis
8.3 Molecular Point-of-Care Testing Midstream Analysis
8.4 Molecular Point-of-Care Testing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Molecular Point-of-Care Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Molecular Point-of-Care Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Molecular Point-of-Care Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Molecular Point-of-Care Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Molecular Point-of-Care Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Molecular Point-of-Care Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Molecular Point-of-Care Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Molecular Point-of-Care Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Molecular Point-of-Care Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Molecular Point-of-Care Testing Players in 2022
Table 12. World Molecular Point-of-Care Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Molecular Point-of-Care Testing Company Evaluation Quadrant
Table 14. Head Office of Key Molecular Point-of-Care Testing Player
Table 15. Molecular Point-of-Care Testing Market: Company Product Type Footprint
Table 16. Molecular Point-of-Care Testing Market: Company Product Application Footprint
Table 17. Molecular Point-of-Care Testing Mergers & Acquisitions Activity
Table 18. United States VS China Molecular Point-of-Care Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Molecular Point-of-Care Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Molecular Point-of-Care Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Molecular Point-of-Care Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Molecular Point-of-Care Testing Revenue Market Share (2018-2023)
Table 23. China Based Molecular Point-of-Care Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Molecular Point-of-Care Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Molecular Point-of-Care Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Molecular Point-of-Care Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Molecular Point-of-Care Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Molecular Point-of-Care Testing Revenue Market Share (2018-2023)
Table 29. World Molecular Point-of-Care Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Molecular Point-of-Care Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Molecular Point-of-Care Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Molecular Point-of-Care Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Molecular Point-of-Care Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Molecular Point-of-Care Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Roche Molecular Diagnostics Basic Information, Area Served and Competitors
Table 36. Roche Molecular Diagnostics Major Business
Table 37. Roche Molecular Diagnostics Molecular Point-of-Care Testing Product and Services
Table 38. Roche Molecular Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Roche Molecular Diagnostics Recent Developments/Updates
Table 40. Roche Molecular Diagnostics Competitive Strengths & Weaknesses
Table 41. Salignostics Basic Information, Area Served and Competitors
Table 42. Salignostics Major Business
Table 43. Salignostics Molecular Point-of-Care Testing Product and Services
Table 44. Salignostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Salignostics Recent Developments/Updates
Table 46. Salignostics Competitive Strengths & Weaknesses
Table 47. Saw Diagnostics Basic Information, Area Served and Competitors
Table 48. Saw Diagnostics Major Business
Table 49. Saw Diagnostics Molecular Point-of-Care Testing Product and Services
Table 50. Saw Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Saw Diagnostics Recent Developments/Updates
Table 52. Saw Diagnostics Competitive Strengths & Weaknesses
Table 53. Siemens Healthineer Basic Information, Area Served and Competitors
Table 54. Siemens Healthineer Major Business
Table 55. Siemens Healthineer Molecular Point-of-Care Testing Product and Services
Table 56. Siemens Healthineer Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Siemens Healthineer Recent Developments/Updates
Table 58. Siemens Healthineer Competitive Strengths & Weaknesses
Table 59. Sona Nanotech Basic Information, Area Served and Competitors
Table 60. Sona Nanotech Major Business
Table 61. Sona Nanotech Molecular Point-of-Care Testing Product and Services
Table 62. Sona Nanotech Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Sona Nanotech Recent Developments/Updates
Table 64. Sona Nanotech Competitive Strengths & Weaknesses
Table 65. T2 Biosystems Basic Information, Area Served and Competitors
Table 66. T2 Biosystems Major Business
Table 67. T2 Biosystems Molecular Point-of-Care Testing Product and Services
Table 68. T2 Biosystems Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. T2 Biosystems Recent Developments/Updates
Table 70. T2 Biosystems Competitive Strengths & Weaknesses
Table 71. Talis Biomedical Basic Information, Area Served and Competitors
Table 72. Talis Biomedical Major Business
Table 73. Talis Biomedical Molecular Point-of-Care Testing Product and Services
Table 74. Talis Biomedical Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Talis Biomedical Recent Developments/Updates
Table 76. Talis Biomedical Competitive Strengths & Weaknesses
Table 77. Thermo Fisher Scientific Inc. Basic Information, Area Served and Competitors
Table 78. Thermo Fisher Scientific Inc. Major Business
Table 79. Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Product and Services
Table 80. Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 82. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 83. Veramarx Basic Information, Area Served and Competitors
Table 84. Veramarx Major Business
Table 85. Veramarx Molecular Point-of-Care Testing Product and Services
Table 86. Veramarx Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Veramarx Recent Developments/Updates
Table 88. Veramarx Competitive Strengths & Weaknesses
Table 89. XCR Diagnostics Basic Information, Area Served and Competitors
Table 90. XCR Diagnostics Major Business
Table 91. XCR Diagnostics Molecular Point-of-Care Testing Product and Services
Table 92. XCR Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. XCR Diagnostics Recent Developments/Updates
Table 94. Zhejiang Orient Gene Biotech Basic Information, Area Served and Competitors
Table 95. Zhejiang Orient Gene Biotech Major Business
Table 96. Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Product and Services
Table 97. Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of Molecular Point-of-Care Testing Upstream (Raw Materials)
Table 99. Molecular Point-of-Care Testing Typical Customers
Table 1. World Molecular Point-of-Care Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Molecular Point-of-Care Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Molecular Point-of-Care Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Molecular Point-of-Care Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Molecular Point-of-Care Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Molecular Point-of-Care Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Molecular Point-of-Care Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Molecular Point-of-Care Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Molecular Point-of-Care Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Molecular Point-of-Care Testing Players in 2022
Table 12. World Molecular Point-of-Care Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Molecular Point-of-Care Testing Company Evaluation Quadrant
Table 14. Head Office of Key Molecular Point-of-Care Testing Player
Table 15. Molecular Point-of-Care Testing Market: Company Product Type Footprint
Table 16. Molecular Point-of-Care Testing Market: Company Product Application Footprint
Table 17. Molecular Point-of-Care Testing Mergers & Acquisitions Activity
Table 18. United States VS China Molecular Point-of-Care Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Molecular Point-of-Care Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Molecular Point-of-Care Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Molecular Point-of-Care Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Molecular Point-of-Care Testing Revenue Market Share (2018-2023)
Table 23. China Based Molecular Point-of-Care Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Molecular Point-of-Care Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Molecular Point-of-Care Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Molecular Point-of-Care Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Molecular Point-of-Care Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Molecular Point-of-Care Testing Revenue Market Share (2018-2023)
Table 29. World Molecular Point-of-Care Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Molecular Point-of-Care Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Molecular Point-of-Care Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Molecular Point-of-Care Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Molecular Point-of-Care Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Molecular Point-of-Care Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Roche Molecular Diagnostics Basic Information, Area Served and Competitors
Table 36. Roche Molecular Diagnostics Major Business
Table 37. Roche Molecular Diagnostics Molecular Point-of-Care Testing Product and Services
Table 38. Roche Molecular Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Roche Molecular Diagnostics Recent Developments/Updates
Table 40. Roche Molecular Diagnostics Competitive Strengths & Weaknesses
Table 41. Salignostics Basic Information, Area Served and Competitors
Table 42. Salignostics Major Business
Table 43. Salignostics Molecular Point-of-Care Testing Product and Services
Table 44. Salignostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Salignostics Recent Developments/Updates
Table 46. Salignostics Competitive Strengths & Weaknesses
Table 47. Saw Diagnostics Basic Information, Area Served and Competitors
Table 48. Saw Diagnostics Major Business
Table 49. Saw Diagnostics Molecular Point-of-Care Testing Product and Services
Table 50. Saw Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Saw Diagnostics Recent Developments/Updates
Table 52. Saw Diagnostics Competitive Strengths & Weaknesses
Table 53. Siemens Healthineer Basic Information, Area Served and Competitors
Table 54. Siemens Healthineer Major Business
Table 55. Siemens Healthineer Molecular Point-of-Care Testing Product and Services
Table 56. Siemens Healthineer Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Siemens Healthineer Recent Developments/Updates
Table 58. Siemens Healthineer Competitive Strengths & Weaknesses
Table 59. Sona Nanotech Basic Information, Area Served and Competitors
Table 60. Sona Nanotech Major Business
Table 61. Sona Nanotech Molecular Point-of-Care Testing Product and Services
Table 62. Sona Nanotech Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Sona Nanotech Recent Developments/Updates
Table 64. Sona Nanotech Competitive Strengths & Weaknesses
Table 65. T2 Biosystems Basic Information, Area Served and Competitors
Table 66. T2 Biosystems Major Business
Table 67. T2 Biosystems Molecular Point-of-Care Testing Product and Services
Table 68. T2 Biosystems Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. T2 Biosystems Recent Developments/Updates
Table 70. T2 Biosystems Competitive Strengths & Weaknesses
Table 71. Talis Biomedical Basic Information, Area Served and Competitors
Table 72. Talis Biomedical Major Business
Table 73. Talis Biomedical Molecular Point-of-Care Testing Product and Services
Table 74. Talis Biomedical Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Talis Biomedical Recent Developments/Updates
Table 76. Talis Biomedical Competitive Strengths & Weaknesses
Table 77. Thermo Fisher Scientific Inc. Basic Information, Area Served and Competitors
Table 78. Thermo Fisher Scientific Inc. Major Business
Table 79. Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Product and Services
Table 80. Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 82. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 83. Veramarx Basic Information, Area Served and Competitors
Table 84. Veramarx Major Business
Table 85. Veramarx Molecular Point-of-Care Testing Product and Services
Table 86. Veramarx Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Veramarx Recent Developments/Updates
Table 88. Veramarx Competitive Strengths & Weaknesses
Table 89. XCR Diagnostics Basic Information, Area Served and Competitors
Table 90. XCR Diagnostics Major Business
Table 91. XCR Diagnostics Molecular Point-of-Care Testing Product and Services
Table 92. XCR Diagnostics Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. XCR Diagnostics Recent Developments/Updates
Table 94. Zhejiang Orient Gene Biotech Basic Information, Area Served and Competitors
Table 95. Zhejiang Orient Gene Biotech Major Business
Table 96. Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Product and Services
Table 97. Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of Molecular Point-of-Care Testing Upstream (Raw Materials)
Table 99. Molecular Point-of-Care Testing Typical Customers
LIST OF FIGURES
Figure 1. Molecular Point-of-Care Testing Picture
Figure 2. World Molecular Point-of-Care Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Molecular Point-of-Care Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Molecular Point-of-Care Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Molecular Point-of-Care Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Molecular Point-of-Care Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Molecular Point-of-Care Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Molecular Point-of-Care Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Molecular Point-of-Care Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Molecular Point-of-Care Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Molecular Point-of-Care Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Molecular Point-of-Care Testing Revenue (2018-2029) & (USD Million)
Figure 13. Molecular Point-of-Care Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Molecular Point-of-Care Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Molecular Point-of-Care Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Molecular Point-of-Care Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Molecular Point-of-Care Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Molecular Point-of-Care Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Molecular Point-of-Care Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Molecular Point-of-Care Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Molecular Point-of-Care Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Molecular Point-of-Care Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Molecular Point-of-Care Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Molecular Point-of-Care Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Molecular Point-of-Care Testing Markets in 2022
Figure 27. United States VS China: Molecular Point-of-Care Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Molecular Point-of-Care Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Molecular Point-of-Care Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Molecular Point-of-Care Testing Market Size Market Share by Type in 2022
Figure 31. Polymerase Chain Reaction (PCR)
Figure 32. Loop-mediated Isothermal Amplification (LAMP)
Figure 33. Nucleic Acid Sequence-based Amplification (NASBA)
Figure 34. World Molecular Point-of-Care Testing Market Size Market Share by Type (2018-2029)
Figure 35. World Molecular Point-of-Care Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Molecular Point-of-Care Testing Market Size Market Share by Application in 2022
Figure 37. Infectious Diseases
Figure 38. Genetic Disorders
Figure 39. Pregnancy Testing
Figure 40. Diagnosis of Cancer
Figure 41. Pharmacogenomics
Figure 42. Molecular Point-of-Care Testing Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Molecular Point-of-Care Testing Picture
Figure 2. World Molecular Point-of-Care Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Molecular Point-of-Care Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Molecular Point-of-Care Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Molecular Point-of-Care Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Molecular Point-of-Care Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Molecular Point-of-Care Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Molecular Point-of-Care Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Molecular Point-of-Care Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Molecular Point-of-Care Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Molecular Point-of-Care Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Molecular Point-of-Care Testing Revenue (2018-2029) & (USD Million)
Figure 13. Molecular Point-of-Care Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Molecular Point-of-Care Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Molecular Point-of-Care Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Molecular Point-of-Care Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Molecular Point-of-Care Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Molecular Point-of-Care Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Molecular Point-of-Care Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Molecular Point-of-Care Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Molecular Point-of-Care Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Molecular Point-of-Care Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Molecular Point-of-Care Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Molecular Point-of-Care Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Molecular Point-of-Care Testing Markets in 2022
Figure 27. United States VS China: Molecular Point-of-Care Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Molecular Point-of-Care Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Molecular Point-of-Care Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Molecular Point-of-Care Testing Market Size Market Share by Type in 2022
Figure 31. Polymerase Chain Reaction (PCR)
Figure 32. Loop-mediated Isothermal Amplification (LAMP)
Figure 33. Nucleic Acid Sequence-based Amplification (NASBA)
Figure 34. World Molecular Point-of-Care Testing Market Size Market Share by Type (2018-2029)
Figure 35. World Molecular Point-of-Care Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Molecular Point-of-Care Testing Market Size Market Share by Application in 2022
Figure 37. Infectious Diseases
Figure 38. Genetic Disorders
Figure 39. Pregnancy Testing
Figure 40. Diagnosis of Cancer
Figure 41. Pharmacogenomics
Figure 42. Molecular Point-of-Care Testing Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
